145 related articles for article (PubMed ID: 19506073)
1. Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for {alpha}7 nicotinic receptors.
Bartos M; Price KL; Lummis SC; Bouzat C
J Biol Chem; 2009 Aug; 284(32):21478-87. PubMed ID: 19506073
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of pyrantel selectivity in nicotinic receptors.
Bartos M; Rayes D; Bouzat C
Mol Pharmacol; 2006 Oct; 70(4):1307-18. PubMed ID: 16825485
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans.
Raymond V; Mongan NP; Sattelle DB
Neuroscience; 2000; 101(3):785-91. PubMed ID: 11113327
[TBL] [Abstract][Full Text] [Related]
4. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
[TBL] [Abstract][Full Text] [Related]
5. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Biton B; Bergis OE; Galli F; Nedelec A; Lochead AW; Jegham S; Godet D; Lanneau C; Santamaria R; Chesney F; Léonardon J; Granger P; Debono MW; Bohme GA; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Vigé X; Voltz C; Rouquier L; Souilhac J; Santucci V; Gueudet C; Françon D; Steinberg R; Griebel G; Oury-Donat F; George P; Avenet P; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):1-16. PubMed ID: 17019409
[TBL] [Abstract][Full Text] [Related]
6. Effects of mutations of a glutamine residue in loop D of the alpha7 nicotinic acetylcholine receptor on agonist profiles for neonicotinoid insecticides and related ligands.
Shimomura M; Okuda H; Matsuda K; Komai K; Akamatsu M; Sattelle DB
Br J Pharmacol; 2002 Sep; 137(2):162-9. PubMed ID: 12208772
[TBL] [Abstract][Full Text] [Related]
7. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.
Fucile S; Palma E; Eusebi F; Miledi R
Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381
[TBL] [Abstract][Full Text] [Related]
8. Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle.
Rayes D; Flamini M; Hernando G; Bouzat C
Mol Pharmacol; 2007 May; 71(5):1407-15. PubMed ID: 17314321
[TBL] [Abstract][Full Text] [Related]
9. Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation.
Cesa LC; Higgins CA; Sando SR; Kuo DW; Levandoski MM
Mol Pharmacol; 2012 Feb; 81(2):239-49. PubMed ID: 22064677
[TBL] [Abstract][Full Text] [Related]
10. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
11. The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.
Seo S; Henry JT; Lewis AH; Wang N; Levandoski MM
J Neurosci; 2009 Jul; 29(27):8734-42. PubMed ID: 19587280
[TBL] [Abstract][Full Text] [Related]
12. Activation and cooperative multi-ion block of single nicotinic-acetylcholine channel currents of Ascaris muscle by the tetrahydropyrimidine anthelmintic, morantel.
Evans AM; Martin RJ
Br J Pharmacol; 1996 Jul; 118(5):1127-40. PubMed ID: 8818335
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
Papke RL; Schiff HC; Jack BA; Horenstein NA
Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site.
Williams DK; Stokes C; Horenstein NA; Papke RL
J Pharmacol Exp Ther; 2009 Jul; 330(1):40-53. PubMed ID: 19339660
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitter GABA activates muscle but not α7 nicotinic receptors.
Dionisio L; Bergé I; Bravo M; Esandi Mdel C; Bouzat C
Mol Pharmacol; 2015; 87(3):391-400. PubMed ID: 25492812
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, alpha7.
Vazquez RW; Oswald RE
Mol Pharmacol; 1999 Jan; 55(1):1-7. PubMed ID: 9882691
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial mutations in loops D and F strongly influence responses of the alpha7 nicotinic acetylcholine receptor to imidacloprid.
Shimomura M; Yokota M; Okumura M; Matsuda K; Akamatsu M; Sattelle DB; Komai K
Brain Res; 2003 Nov; 991(1-2):71-7. PubMed ID: 14575878
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nicotinic acetylcholine receptors by bicuculline.
Demuro A; Palma E; Eusebi F; Miledi R
Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149
[TBL] [Abstract][Full Text] [Related]
19. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
[TBL] [Abstract][Full Text] [Related]
20. Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.
Wu TY; Smith CM; Sine SM; Levandoski MM
Mol Pharmacol; 2008 Aug; 74(2):466-75. PubMed ID: 18458055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
